COM:REGENERON
Regeneron Pharmaceuticals, Inc.
- Stock
Last Close
744.50
22/11 21:00
Market Cap
116.07B
Beta: -
Volume Today
1.03M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 348.07M - | 636.06M 82.74% | 895.52M 40.79% | 1.20B 33.83% | 2.44B 103.95% | 2.12B 13.44% | 3.51B 66.05% | 8.08B 129.86% | 4.34B 46.28% | 3.95B 8.87% | |
depreciation and amortization | 52.69M - | 74.91M 42.18% | 104.75M 39.83% | 145.47M 38.88% | 148.20M 1.88% | 210.30M 41.90% | 235.90M 12.17% | 286.20M 21.32% | 341.40M 19.29% | 421M 23.32% | |
deferred income tax | -66.60M - | -121.62M 82.61% | -360.08M 196.06% | 318.81M 188.54% | -140M 143.91% | -130.60M 6.71% | 75.60M 157.89% | -147.10M 294.58% | -746.40M 407.41% | -837.80M 12.25% | |
stock based compensation | 307.24M - | 459.05M 49.41% | 559.88M 21.96% | 507.28M 9.40% | 427.40M 15.75% | 464.30M 8.63% | 432M 6.96% | 601.70M 39.28% | 725M 20.49% | 885M 22.07% | |
change in working capital | 20.24M - | 229.83M 1,035.56% | 228.19M 0.71% | -926.53M 506.04% | -697M 24.77% | -200.50M 71.23% | -1.50B 649.93% | -1.92B 27.46% | -243.30M 87.30% | -94.10M 61.32% | |
accounts receivables | -62.43M - | -491.42M 687.13% | -143.83M 70.73% | -362.72M 152.19% | -268.90M 25.87% | -473.10M 75.94% | -1.36B 186.64% | -1.93B 42.13% | 707.80M 136.72% | -338.80M 147.87% | |
inventory | -60.90M - | -111.83M 83.62% | -149.78M 33.94% | -314.19M 109.78% | -387.90M 23.46% | -335.50M 13.51% | -529.40M 57.79% | -494.30M 6.63% | -696.50M 40.91% | -271.70M 60.99% | |
accounts payables | 162.24M - | 303.66M 87.17% | 253.98M 16.36% | -23.19M 109.13% | 210M 1,005.64% | 444.50M 111.67% | 118.90M 73.25% | 866.10M 628.43% | -138.40M 115.98% | 598.60M 532.51% | |
other working capital | -18.66M - | 529.42M 2,936.41% | 267.81M 49.41% | -226.43M 184.55% | -250.20M 10.50% | 163.60M 165.39% | 263M 60.76% | -360.90M 237.22% | -116.20M 67.80% | -82.20M 29.26% | |
other non cash items | 361.62M - | 619.82M 71.40% | 485.70M 21.64% | -36.90M 107.60% | 12.10M 132.79% | -29.30M 342.15% | -135M 360.75% | 181.70M 234.59% | 599.80M 230.10% | 266.30M 55.60% | |
net cash provided by operating activities | 752.43M - | 1.33B 76.86% | 1.49B 11.66% | 1.31B 12.03% | 2.20B 67.94% | 2.43B 10.70% | 2.62B 7.74% | 7.08B 170.47% | 5.01B 29.18% | 4.59B 8.39% | |
investments in property plant and equipment | -333.01M - | -677.93M 103.58% | -511.90M 24.49% | -272.60M 46.75% | -383.10M 40.54% | -429.60M 12.14% | -614.60M 43.06% | -551.90M 10.20% | -590.10M 6.92% | -926.40M 56.99% | |
acquisitions net | 1.07B - | 429.60M 59.85% | 614.60M 43.06% | 551.90M 10.20% | -230.30M 141.73% | -54.90M 76.16% | |||||
purchases of investments | -564.19M - | -557.11M 1.26% | -809.42M 45.29% | -1.28B 57.78% | -1.85B 44.50% | -3.20B 73.52% | -3.24B 1.21% | -7.05B 117.47% | -7.49B 6.24% | -11.65B 55.53% | |
sales maturities of investments | 476.42M - | 327.44M 31.27% | 274.46M 16.18% | 544.58M 98.42% | 775.60M 42.42% | 1.60B 106.83% | 3.79B 135.94% | 2.22B 41.47% | 5.55B 150.55% | 9.44B 70.11% | |
other investing activites | -87.77M - | -229.67M 161.67% | -534.90M 132.90% | -732.60M 36.96% | -1.08B 47.41% | -429.60M 60.22% | -614.60M 43.06% | -551.90M 10.20% | -1.03B 86.05% | ||
net cash used for investing activites | -420.78M - | -907.60M 115.70% | -1.05B 15.35% | -1.01B 3.99% | -1.46B 45.55% | -2.03B 38.61% | -70.60M 96.52% | -5.38B 7,527.05% | -3.78B 29.72% | -3.19B 15.84% | |
debt repayment | -221.73M - | -166.47M 24.92% | -40.58M 75.62% | -19.93M 50.90% | -1.50B - | ||||||
common stock issued | 126.05M - | 206.36M 63.72% | 126.74M 38.58% | 240.21M 89.53% | 114.50M 52.33% | 211.80M 84.98% | 2.58B 1,115.86% | 1.67B 35.06% | 1.52B 9.14% | 1.15B 24.61% | |
common stock repurchased | -267.58M - | -160.54M 40.01% | -143.18M 10.81% | -301.69M 110.70% | -191.60M 36.49% | -463.90M 142.12% | -6.53B 1,307.11% | -2.68B 58.97% | -2.53B 5.59% | -2.94B 16.10% | |
dividends paid | -294.55M - | -547.47M 85.86% | -500.18M 8.64% | -358.69M 28.29% | |||||||
other financing activites | 448.56M - | 405.32M 9.64% | -143.18M 135.33% | 415.69M 390.32% | -188M - | 3.48B 1,952.07% | |||||
net cash used provided by financing activities | -209.27M - | -262.80M 25.58% | -700.39M 166.52% | -24.40M 96.52% | -77.10M 215.98% | -252.10M 226.98% | -1.97B 681.63% | -1.01B 48.96% | -1.01B 0.32% | -1.79B 77.41% | |
effect of forex changes on cash | -400K - | ||||||||||
net change in cash | 113.11M - | 160.38M 41.79% | -273.90M 270.78% | 277.53M 201.33% | 655M 136.01% | 150.10M 77.08% | 577M 284.41% | 690.80M 19.72% | 221.30M 67.96% | -381.60M 272.44% | |
cash at beginning of period | 535.61M - | 648.72M 21.12% | 809.10M 24.72% | 535.20M 33.85% | 825.20M 54.18% | 1.48B 79.37% | 1.63B 10.14% | 2.21B 35.39% | 2.90B 31.30% | 3.12B 7.64% | |
cash at end of period | 648.72M - | 809.10M 24.72% | 535.20M 33.85% | 812.73M 51.86% | 1.48B 82.13% | 1.63B 10.14% | 2.21B 35.39% | 2.90B 31.30% | 3.12B 7.64% | 2.74B 12.23% | |
operating cash flow | 752.43M - | 1.33B 76.86% | 1.49B 11.66% | 1.31B 12.03% | 2.20B 67.94% | 2.43B 10.70% | 2.62B 7.74% | 7.08B 170.47% | 5.01B 29.18% | 4.59B 8.39% | |
capital expenditure | -333.01M - | -677.93M 103.58% | -511.90M 24.49% | -272.60M 46.75% | -383.10M 40.54% | -429.60M 12.14% | -614.60M 43.06% | -551.90M 10.20% | -590.10M 6.92% | -926.40M 56.99% | |
free cash flow | 419.43M - | 652.85M 55.65% | 974M 49.19% | 1.03B 6.21% | 1.81B 75.16% | 2.00B 10.40% | 2.00B 0.15% | 6.53B 225.90% | 4.42B 32.23% | 3.67B 17.11% |
All numbers in USD (except ratios and percentages)